Strategies to Improve Global Patient Adherence
Contributor:
Pharma IQ
Posted: 05/12/2011 12:00:00 AM EDT | 0
Part of the solution to improving patient adherence,as seen by many, is the increased use of new technology.
Posted: 05/12/2011 12:00:00 AM EDT | 0
|
-
The Role of Cessation Services in Quitting Smoking and Future Directions -
Can New Media Improve the Output of Pharmacovigilance Data? -
Cost Savings Still the Number One Reason Behind 60% of Outsourced Pharma and Bio Manufacturing -
GCC Paediatric Healthcare Strategies -
FDA to Issue Guidance on the Biosimilar Pathway by End of 2011 -
Realising the Demand for Affordable Healthcare: Opportunities and Challenges -
Interoperability a Concern in 82.4% of Laboratories Progressing Toward the 'Paperless' Ideal -
Pharma IQ Top Blogger Awards 2011 - Legal & Regulatory -
The FDA Makes Almost Daily Use of Social Media, What is Stopping You? -
Challenges and Benefits of Patient-Based Phase I Trials
* = required.
Not a member yet? Sign up
You Should Check Out:
Events of Interest
-
Patient Flow Optimisation Asia 2012
Prince Hotel & Residence, Kuala Lumpur, Malaysia
June 20- 21, 2012 -
3rd Annual Global Clinical Outsourcing Forum
Mercure Hotel Amsterdam Aan de Amstel, Amsterdam
April 24- 25, 2012 -
Global Formulation and Drug Delivery Summit 2012
Park Hotel Amsterdam, Netherlands
April 16- 18, 2012 -
2nd Annual Early Phase Clinical Trials Asia
Venue to be Confirmed, Singapore
August 28- 29, 2012
You Might Also Like
-
Novo Nordisk's Søren Skovlund Speaks to Pharma IQ about Best Practice Approaches to Patient Education and Self-Management
Søren Skovlund is director of global patient research, advocacy and support in Novo Nordisk and... Read more
Soren Skovlund
-
Sharpen up on Patient Self-Management Approaches
Soren Skovlund, Director of Patient Research, Advocacy and Support at NovoNordisk, joins Helen Winsor from
Helen Winsor
-
30% of Diabetes Patients Admit Skipping Insulin Injections
Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems
Helen Winsor
-
Stumbling Blocks for Patient Compliance in Parkinson’s Disease Treatment
Nicolas Favre, International Brand Manager, Azilect at Lundbeck, joins Pharma IQ to discuss the commonly
Helen Winsor






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!